SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-10-029861
Filing Date
2010-02-12
Accepted
2010-02-12 10:10:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A dsc13ga.htm SC 13G/A 39976
  Complete submission text file 0001193125-10-029861.txt   41663
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Subject) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48083 | Film No.: 10595031
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address PPD INC 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address
ESHELMAN FREDRIC N (Filed by) CIK: 0001033409 (see all company filings)

Type: SC 13G/A